King of Prussia, PA, United States of America

Roland Ellwood Dolle

This inventor holds 81 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry (CPC class C07D-). Top assignees: Adolor Corporation, Pharmacopeia Inc., Vertex Pharmaceuticals, Inc.. Active years: 1995-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Ellwood Dolle. Retrieved from https://idiyas.com/inventor/roland-ellwood-dolle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 56.8

 

Average Co-Inventor Count = 3.5

ph-index = 16

Forward Citations = 591(Granted Patents)

Forward Citations (Not Self Cited) = 549(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Pottstown, PA (US) (1996 - 1997)
  • King of Prussia, PA (US) (1995 - 2013)
  • Hopkinton, MA (US) (2013 - 2015)
  • Ashland, MA (US) (2014 - 2015)

Company Filing History:


Years Active: 1995-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Beta-Lactamase Inhibitors
Opioid Antagonists
Piperidine Compounds
Spirocyclic Derivatives
Pain Treatment
N-Heterocyclic Derivatives
Phenyl Derivatives
Amide Derivatives
Bicyclic Carboxamide Derivatives
81 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the article about inventor Roland Ellwood Dolle.

Title: The Innovative Journey of Roland Ellwood Dolle

Introduction:

Roland Ellwood Dolle is a prolific inventor based in King of Prussia, PA (US). With an impressive track record of 81 patents to his name, he has made significant contributions to the field of pharmaceuticals and healthcare.

Latest Patents:

One of Dolle's groundbreaking inventions includes Beta-lactamase inhibitors - Aryl substituted diazabicyclooctanes (DBO) compounds that inhibit β-lactamases of class A, class C, or class D and potentiate β-lactam antibiotics. These compounds have shown exceptional efficacy with a minimal inhibitory concentration (MIC) of 8 μg/mL or less against isogenic β-lactamase-expressing bacterial strains.

Career Highlights:

Throughout his career, Dolle has been associated with renowned companies such as Adolor Corporation and Pharmacopeia Inc., where he has spearheaded research and development initiatives aimed at addressing critical healthcare challenges.

Collaborations:

Dolle has collaborated closely with accomplished professionals in the industry, including Bertrand Le Bourdonnec and Stanley J Schmidt. These collaborations have led to the successful development and commercialization of innovative pharmaceutical solutions.

Conclusion:

Roland Ellwood Dolle's inventive spirit and dedication to advancing healthcare through his patented inventions have solidified his reputation as a pioneer in the field. His relentless pursuit of scientific excellence continues to inspire future generations of inventors and researchers.

If you have any more requests or need additional information, feel free to ask.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…